Business Context and Reporting Period
Company: Transmation, Inc. (Note: Input metadata lists "TRANSCAT INC", but the filing identifies the registrant as Transmation, Inc., with Transcat as a division).
Reporting Period: Fiscal year ended March 31, 2001.
Business Overview: Transmation is engaged in the sale, distribution, development, manufacture, and service of electronic instrumentation for measurement and calibration. Principal markets include petroleum refining, chemical manufacturing, pulp and paper, and pharmaceutical industries. The company operates through its Transcat Distribution Division, a manufacturing subsidiary (The Products Group), an online subsidiary (MetersandInstruments.com), and a foreign subsidiary.
Key Financial Metrics
Note: This filing explicitly excludes Item 6 (Selected Financial Data), Item 7 (MD&A), and Item 8 (Financial Statements). Consequently, specific revenue, profit, cash flow, margin, debt, and liquidity figures are not provided in the text.
- Revenue/Profit/Cash Flow: Not provided in this document.
- Backlog: Firm order backlog was approximately $2,515,000 as of March 31, 2001.
- Research & Development: Expenditures were approximately $1,165,953 for fiscal 2001.
- Market Capitalization: Aggregate market value of voting stock held by non-affiliates was $13,823,458 as of May 31, 2001.
- Stock Price Range (Fiscal 2001): High of $3.75 (Q2) to Low of $0.88 (Q3).
- Employees: 345 total (including 7 part-time) as of March 31, 2001.
Material Changes vs. Prior Period
- Backlog: Decreased to $2,515,000 in 2001 from $3,125,000 in 2000 and $2,483,000 in 1999.
- R&D Spending: Decreased to approximately $1.17 million in 2001 from $1.51 million in 2000 and $1.62 million in 1999.
- Foreign Sales: Declined to 14.0% of total sales in 2001 from 14.9% in 2000 and 18.8% in 1999. Management attributes this to a stronger U.S. dollar and continued weakness in Asian currencies.
- Workforce: Employee count decreased to 345 in 2001 from 351 in 2000 and 418 in 1999.
- Stock Performance: Significant volatility observed in 2001, with the stock price dropping to a low of $0.88 in the third quarter, compared to a high of $4.50 in the first quarter of 2000.
Outlook, Risks, and Contingencies
- Joint Venture: Entered a joint venture in 2001 (49% interest) to perform calibration services in Puerto Rico, operational as of May 2000.
- Competition: The market is highly competitive. Major competitors include Fluke (Danaher), Beta (Hathaway), and divisions of Ametek. The company faces risks from competitors with greater financial resources and technological capabilities.
- Supply Chain: Manufacturing operations depend on timely delivery of components. Delays have occurred due to demand and long lead times, though no material adverse effect has been recorded to date.
- Product Liability: Products are used in industries with low tolerance for error. Defects could lead to recalls, liability claims, and reputational damage. Insurance costs are high and coverage may be limited.
- Intellectual Property: Management believes patents are not essential to the business but hold several U.S. patents expiring through 2012. Risks include infringement claims and inability to enforce proprietary rights.
- Dividends: The company has paid no cash dividends since its inception.
Investor Verification Checklist
- Financial Statements: Verify actual revenue, net income, and cash flow figures in the full Form 10-K (Items 6, 7, and 8 are excluded from this text summary).
- Debt Obligations: Review the Credit and Loan Agreement with KeyBank National Association (referenced in Exhibits) for current debt levels and covenants.
- Stock Price Volatility: Investigate the causes of the significant stock price decline in Q3 2001 (low of $0.88) compared to prior periods.
- Foreign Exchange Impact: Assess the sensitivity of future earnings to U.S. dollar strength, particularly regarding Asian markets.
- Backlog Conversion: Confirm the realization of the $2.5 million backlog in fiscal 2002 as anticipated by management.